A Study To Test PF-04449913 (Glasdegib) With Intensive or Non-Intensive Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

A Phase 1b/2 Study to Evaluate the Safety and Efficacy of PF-04449913, an Oral Hedgehog Inhibitor, in Combination With Intensive Chemotherapy, Low Dose Ara-C or Decitabine in Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Category & Conditions:
Cancer
Medicine:
DAURISMO TABLETS(GLASDEGIB)
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B1371003
Open Plain Language Summary Result:Click here